Novavax Inc. buy jomobb
.jpg?locale=us "jomobb")
Start price
28.05.21
/
80%
€125.18
Target price
28.05.22
€200.00
Performance (%)
-35.69%
End price
29.01.22
€80.50
Summary
This prediction ended on 29.01.22 with a price of €80.50. Massive losses of -35.69% were the result for the BUY prediction by jomobb. jomobb has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novavax Inc. | -4.631% | -4.631% | 3.682% | -8.115% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
According to jomobb what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies